Effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis
We investigated the effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis for 3 and 5 years. Significant improvement found the decrease of the frequency of clinical exacerbations and delay the accumulation of physical disability during treatment period.
Asıl Yazarlar: | V. M. Alifirova, M. A. Titova, A. A. Vereschaka |
---|---|
Materyal Türü: | Makale |
Dil: | English |
Baskı/Yayın Bilgisi: |
Siberian State Medical University (Tomsk)
2010-08-01
|
Seri Bilgileri: | Бюллетень сибирской медицины |
Konular: | |
Online Erişim: | https://bulletin.ssmu.ru/jour/article/view/1618 |
Benzer Materyaller
-
Copaxone in therapy of remittent disseminated sclerosis patients
Yazar:: O. A. Kitcherova, ve diğerleri
Baskı/Yayın Bilgisi: (2008-09-01) -
Epidemiological characteristics of multiple sclerosis in Tomsk Region and their dynamics for last 30 years
Yazar:: V. M. Alifirova, ve diğerleri
Baskı/Yayın Bilgisi: (2012-06-01) -
Prospects of laboratory risk evaluation of multiple sclerosis relapse and progressing
Yazar:: I. V. Smagina, ve diğerleri
Baskı/Yayın Bilgisi: (2010-08-01) -
ATYPICAL FORMS OF MULTIPLE SCLEROSIS IN THE TOMSK REGION
Yazar:: V. M. Alifirova, ve diğerleri
Baskı/Yayın Bilgisi: (2013-10-01) -
Cognitive disturbances in patients with multiple sclerosis
Yazar:: V. M. Alifirova, ve diğerleri
Baskı/Yayın Bilgisi: (2008-09-01)